含氮碱基的新型磺酰胺碳酸酐酶IX抑制剂的发现。
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases.
作者信息
Nocentini Alessio, Bua Silvia, Lomelino Carrie L, McKenna Robert, Menicatti Marta, Bartolucci Gianluca, Tenci Barbara, Di Cesare Mannelli Lorenzo, Ghelardini Carla, Gratteri Paola, Supuran Claudiu T
机构信息
Department of NEUROFARBA, Pharmaceutical and Nutraceutical section, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Box 100245, Gainesville, Florida 32610, United States.
出版信息
ACS Med Chem Lett. 2017 Nov 21;8(12):1314-1319. doi: 10.1021/acsmedchemlett.7b00399. eCollection 2017 Dec 14.
Abstract
Incorporation of the purine/pyrimidine moieties as tails to classical benzenesulfonamide scaffolds afforded two series of human (h) carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. The compounds were designed according to the molecular hybridization approach, in order to modulate the interaction with different CA isozymes and exploit the antitumor effect of uracil and adenine derivatives in parallel and synergic mode to the inhibition of the tumor-associated hCA IX. The sulfonamides were investigated as inhibitors of four isoforms, cytosolic hCA I/II and transmembrane hCA IV/IX. The inhibitory profiles were dependent on the length and positioning of the spacer connecting the two pharmacophores. X-ray crystallography demonstrated the binding mode of an inhibitor to hCA II and hCA IX-mimic. Compounds endowed with the best hCA IX inhibitory efficacy were evaluated for antiproliferative activity against HT-29 colon cancer cell lines. The results suggest multiple mechanisms of action are responsible for the compounds' cytotoxic efficacy.
摘要
将嘌呤/嘧啶部分作为尾巴引入经典的苯磺酰胺支架，得到了两个系列的人（h）碳酸酐酶（CA，EC 4.2.1.1）抑制剂。这些化合物是根据分子杂交方法设计的，目的是调节与不同CA同工酶的相互作用，并以平行和协同的方式利用尿嘧啶和腺嘌呤衍生物的抗肿瘤作用来抑制肿瘤相关的hCA IX。研究了这些磺酰胺作为四种同工型（胞质hCA I/II和跨膜hCA IV/IX）抑制剂的情况。抑制谱取决于连接两个药效基团的间隔基的长度和位置。X射线晶体学证明了一种抑制剂与hCA II和hCA IX模拟物的结合模式。对具有最佳hCA IX抑制效力的化合物进行了针对HT-29结肠癌细胞系的抗增殖活性评估。结果表明，多种作用机制导致了这些化合物的细胞毒性效力。
相似文献
1
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases.含氮碱基的新型磺酰胺碳酸酐酶IX抑制剂的发现。
ACS Med Chem Lett. 2017 Nov 21;8(12):1314-1319. doi: 10.1021/acsmedchemlett.7b00399. eCollection 2017 Dec 14.
2
Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.碳酸酐酶抑制剂。新型 N-取代的 N'-(2-芳甲基硫代-4-氯-5-甲基苯磺酰)胍的合成及分子结构及其对人胞质同工酶 I 和 II 以及跨膜肿瘤相关同工酶 IX 和 XII 的抑制作用。
Eur J Med Chem. 2014 Jan;71:135-47. doi: 10.1016/j.ejmech.2013.10.081. Epub 2013 Nov 10.
3
5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.5-取代-(1,2,3-三唑-4-基)噻吩-2-磺酰胺类强烈抑制人碳酸酐酶 I、II、IX 和 XII：溶液和 X 射线晶体学研究。
Bioorg Med Chem. 2013 Sep 1;21(17):5130-8. doi: 10.1016/j.bmc.2013.06.041. Epub 2013 Jun 27.
4
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.新型席夫碱对碳酸酐酶同工型I、II、IX和XII的抑制作用：肿瘤相关同工型相对于胞质同工型的选择性抑制剂的鉴定。
Bioorg Med Chem. 2014 Nov 1;22(21):5883-90. doi: 10.1016/j.bmc.2014.09.021. Epub 2014 Sep 21.
5
Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.碳酸酐酶抑制剂：含4-和3-硝基邻苯二甲酰亚胺部分的苯磺酰胺对人碳酸酐酶同工酶I、II、IX和XII的合成及抑制作用
Bioorg Med Chem. 2014 Mar 1;22(5):1586-95. doi: 10.1016/j.bmc.2014.01.031. Epub 2014 Jan 31.
6
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.碳酸酐酶抑制剂：含1,2,4-三嗪部分的磺酰胺类化合物对胞质/肿瘤相关碳酸酐酶同工酶I、II和IX的合成及抑制作用
Bioorg Med Chem Lett. 2004 Nov 1;14(21):5427-33. doi: 10.1016/j.bmcl.2004.07.087.
7
Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.碳酸酐酶抑制剂。含色酮和芳族磺酰胺部分的席夫碱及其锌配合物对胞质/肿瘤相关碳酸酐酶同工酶I、II、IX和XII的抑制作用。
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3096-101. doi: 10.1016/j.bmcl.2005.04.055.
8
Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.新型磺酰胺类化合物，包含 1,3,5-三嗪和氨基酸结构基序，作为生理碳酸酐酶同工酶 I、II 和 IV 以及肿瘤相关同工酶 IX 的抑制剂。
Bioorg Chem. 2018 Dec;81:241-252. doi: 10.1016/j.bioorg.2018.08.005. Epub 2018 Aug 16.
9
Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.新型芳香族和杂环双磺酰胺席夫碱作为碳酸酐酶I、II、VII和IX抑制剂的合成及生物学评价
Bioorg Med Chem. 2017 Jun 15;25(12):3093-3097. doi: 10.1016/j.bmc.2017.03.063. Epub 2017 Mar 31.
10
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.碳酸酐酶抑制剂：新型磺酰胺类化合物，包含1,3,5-三嗪部分，作为胞质和肿瘤相关碳酸酐酶同工酶I、II和IX的抑制剂。
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3102-8. doi: 10.1016/j.bmcl.2005.04.056.
引用本文的文献
1
2
The Mechanism of Anti-Tumor Activity of 6-Morpholino- and 6-Amino-9-Sulfonylpurine Derivatives on Human Leukemia Cells.6-吗啉基和 6-氨基-9-磺基嘌呤衍生物对人白血病细胞抗肿瘤活性的作用机制。
Molecules. 2023 Aug 19;28(16):6136. doi: 10.3390/molecules28166136.
3
Pyrazole-sulfonamide scaffold featuring dual-tail strategy as apoptosis inducers in colon cancer.具有双重靶向策略的吡唑-磺胺骨架作为结肠癌凋亡诱导剂。
Sci Rep. 2023 Apr 8;13(1):5782. doi: 10.1038/s41598-023-32820-0.
4
Design and synthesis of some new benzoylthioureido phenyl derivatives targeting carbonic anhydrase enzymes.设计和合成一些新的苯甲酰硫脲基苯基衍生物，作为碳酸酐酶酶的靶点。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2702-2709. doi: 10.1080/14756366.2022.2126463.
5
Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors.肉桂醛-硫代缩氨基脲双药效团作为有效的碳酸酐酶-II 抑制剂。
Sci Rep. 2022 Sep 27;12(1):16095. doi: 10.1038/s41598-022-19975-y.
6
Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies.靶向碳酸酐酶 IX 和 XII 同工型的小分子抑制剂和单克隆抗体。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1278-1298. doi: 10.1080/14756366.2022.2052868.
7
Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors.异香豆素：一类新型的碳酸酐酶 IX 和 XII 抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):743-748. doi: 10.1080/14756366.2022.2041630.
8
Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms.含磺酸基的芳基磺酰胺类化合物：新型膜不可渗透碳酸酐酶抑制剂，可选择性靶向与癌症相关的同工酶。
Int J Mol Sci. 2021 Dec 31;23(1):461. doi: 10.3390/ijms23010461.
9
Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.抑制碳酸酐酶 IX 和 XII 的活性作为开发新型抗癌药物的候选物选择标准。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1555-1561. doi: 10.1080/14756366.2020.1801674.
10
Drug Screening in Human Cells by NMR Spectroscopy Allows the Early Assessment of Drug Potency.通过 NMR 光谱法在人类细胞中进行药物筛选可早期评估药物效力。
Angew Chem Int Ed Engl. 2020 Apr 16;59(16):6535-6539. doi: 10.1002/anie.201913436. Epub 2020 Feb 25.
本文引用的文献
1
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.碳酸酐酶抑制与缺氧肿瘤的治疗
Metabolites. 2017 Sep 16;7(3):48. doi: 10.3390/metabo7030048.
2
Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.具有强效碳酸酐酶II和VII抑制特性的含异恶唑磺酰胺的合成。
Bioorg Med Chem. 2017 Feb 15;25(4):1456-1464. doi: 10.1016/j.bmc.2017.01.008. Epub 2017 Jan 11.
3
Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations.含柔性三唑部分的苯磺酰胺是高效碳酸酐酶抑制剂：合成及动力学、晶体学、计算和降低眼压研究
J Med Chem. 2016 Dec 8;59(23):10692-10704. doi: 10.1021/acs.jmedchem.6b01389. Epub 2016 Nov 21.
4
Advances in structure-based drug discovery of carbonic anhydrase inhibitors.基于结构的碳酸酐酶抑制剂药物发现进展
Expert Opin Drug Discov. 2017 Jan;12(1):61-88. doi: 10.1080/17460441.2017.1253677. Epub 2016 Nov 9.
5
How many carbonic anhydrase inhibition mechanisms exist?存在多少种碳酸酐酶抑制机制？
J Enzyme Inhib Med Chem. 2016;31(3):345-60. doi: 10.3109/14756366.2015.1122001. Epub 2015 Nov 30.
6
Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.对肿瘤相关碳酸酐酶IX和XII具有强效和选择性抑制作用的咔嗒尾香豆素。
Bioorg Med Chem. 2015 Nov 1;23(21):6955-66. doi: 10.1016/j.bmc.2015.09.041. Epub 2015 Sep 28.
7
Synthesis and pharmacophore modelling of 2,6,9-trisubstituted purine derivatives and their potential role as apoptosis-inducing agents in cancer cell lines.2,6,9-三取代嘌呤衍生物的合成、药效团建模及其在癌细胞系中作为凋亡诱导剂的潜在作用。
Molecules. 2015 Apr 15;20(4):6808-26. doi: 10.3390/molecules20046808.
8
In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications.寻找作为生物活性剂的尿嘧啶衍生物。尿嘧啶及其稠合尿嘧啶：合成、生物活性及应用。
Eur J Med Chem. 2015 Jun 5;97:582-611. doi: 10.1016/j.ejmech.2014.10.008. Epub 2014 Oct 5.
9
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.缺氧诱导的碳酸酐酶 IX 作为癌症治疗的靶点：从生物学到临床应用。
Semin Cancer Biol. 2015 Apr;31:52-64. doi: 10.1016/j.semcancer.2014.08.002. Epub 2014 Aug 10.
10
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.抗癌杂合物的合理方法、设计策略、构效关系及作用机制洞察
Eur J Med Chem. 2014 Apr 22;77:422-87. doi: 10.1016/j.ejmech.2014.03.018. Epub 2014 Mar 12.
Zotero 插件